FI972460L - Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus - Google Patents

Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus Download PDF

Info

Publication number
FI972460L
FI972460L FI972460A FI972460A FI972460L FI 972460 L FI972460 L FI 972460L FI 972460 A FI972460 A FI 972460A FI 972460 A FI972460 A FI 972460A FI 972460 L FI972460 L FI 972460L
Authority
FI
Finland
Prior art keywords
nitric oxide
inhibitory activity
oxide synthase
aniline derivatives
synthase inhibitory
Prior art date
Application number
FI972460A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972460A7 (fi
FI972460A0 (fi
Inventor
Toshio Honda
Toshihiko Makino
Toshiaki Nagafuji
Yasushi Kitoh
Nobuaki Kimura
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI972460A0 publication Critical patent/FI972460A0/fi
Publication of FI972460L publication Critical patent/FI972460L/fi
Publication of FI972460A7 publication Critical patent/FI972460A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/19Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C07C205/37Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32N-nitroguanidines
    • C07C279/36Substituted N-nitroguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/32Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/14Compounds containing a carbon atom having four bonds to hetero atoms with a double bond to one hetero atom and at least one bond to a sulfur atom further doubly-bound to oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
FI972460A 1994-12-12 1995-12-12 Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus FI972460A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33679594 1994-12-12
PCT/JP1995/001135 WO1996018607A1 (fr) 1994-12-12 1995-06-07 Derive d'aniline inhibant la synthase du monoxyde d'azote
PCT/JP1995/002540 WO1996018608A1 (fr) 1994-12-12 1995-12-12 Derives d'aniline a activite inhibant la monoxyde d'azote synthase

Publications (3)

Publication Number Publication Date
FI972460A0 FI972460A0 (fi) 1997-06-10
FI972460L true FI972460L (fi) 1997-08-11
FI972460A7 FI972460A7 (fi) 1997-08-11

Family

ID=18302759

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972460A FI972460A7 (fi) 1994-12-12 1995-12-12 Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus

Country Status (22)

Country Link
US (1) US6534546B1 (fr)
EP (1) EP0798292B1 (fr)
JP (1) JP3655685B2 (fr)
KR (1) KR100339299B1 (fr)
CN (2) CN1075808C (fr)
AT (1) ATE281430T1 (fr)
AU (2) AU2629795A (fr)
BR (1) BR9510006A (fr)
CA (1) CA2206005C (fr)
CZ (1) CZ290655B6 (fr)
DE (1) DE69533727T2 (fr)
ES (1) ES2232828T3 (fr)
FI (1) FI972460A7 (fr)
GE (1) GEP20012439B (fr)
HK (1) HK1039316A1 (fr)
HU (1) HUP0600438A2 (fr)
LT (1) LT4343B (fr)
NO (1) NO310615B1 (fr)
NZ (2) NZ501319A (fr)
RU (1) RU2167858C2 (fr)
TW (1) TW474909B (fr)
WO (2) WO1996018607A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9418912D0 (en) 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
JP4255138B2 (ja) * 1996-05-24 2009-04-15 湧永製薬株式会社 脳疾患治療剤
WO1998057173A1 (fr) * 1997-06-10 1998-12-17 Eli Lilly And Company Processus combinatoire de preparation de bibliotheques de phenylalanine substituee
FR2784678B1 (fr) * 1998-09-23 2002-11-29 Sod Conseils Rech Applic Nouveaux derives de n-(iminomethyl)amines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2783519B1 (fr) * 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AU5851400A (en) * 1999-07-09 2001-01-30 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of aniline derivatives
DE19940389A1 (de) * 1999-08-25 2001-03-01 Wilex Biotechnology Gmbh Selektive Inhibitoren des Urokinase-Plasminogen Aktivators
FR2801053B1 (fr) * 1999-11-16 2004-06-25 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments
CZ20023105A3 (cs) * 2000-03-16 2003-02-12 Société De Conseils De Recherches Et D'application Nové heterocyklické nebo benzenové deriváty kyseliny lipoové, jejich příprava a jejich použití jako léčiv
DE10013715A1 (de) * 2000-03-20 2001-09-27 Wilex Biotechnology Gmbh Hochselektive Inhibitoren des Urokinase-Plasminogenaktivators
WO2001083429A1 (fr) * 2000-04-28 2001-11-08 Chugai Seiyaku Kabushiki Kaisha Derives d'aniline
GB0019357D0 (en) * 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines
GB0019359D0 (en) * 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel guanidines
RU2223952C2 (ru) * 2001-06-04 2004-02-20 Институт физиологически активных веществ РАН Производные n,s-замещенных n'-1-[(гетеро)арил]-n'-[(гетеро)арил]метилизотиомочевин или их солей с фармакологически приемлемыми кислотами нх, способы получения их солей и оснований, фармацевтическая композиция, способ лечения и способ изучения глутаматэргической системы
US7056945B1 (en) * 2002-06-14 2006-06-06 The Regents Of The University Of California Selective inhibition of neuronal nitric oxide synthase
RU2237658C1 (ru) * 2003-07-10 2004-10-10 Общество с ограниченной ответственностью "Международный институт эколого-технологических проблем" Гидрохлорид п-гуанидиносалицилата натрия
BRPI0412502A (pt) * 2003-07-10 2006-09-19 Achillion Pharmaceuticals Inc derivados de ariltiouréia substituìda úteis como inibidores de replicação viral
EP2612854B1 (fr) 2005-10-25 2015-04-29 Shionogi&Co., Ltd. Dérivés d'aminothiazolidine et d'aminotétrahydrothiazepine comme inhibiteurs de BACE 1
WO2008133273A1 (fr) 2007-04-24 2008-11-06 Shionogi & Co., Ltd. Composition pharmaceutique pour le traitement de la maladie d'alzheimer
TW200902526A (en) 2007-04-24 2009-01-16 Shionogi & Amp Co Ltd Aminodihydrothiazin derivative substituted with a cyclic group
WO2009151098A1 (fr) 2008-06-13 2009-12-17 塩野義製薬株式会社 DÉRIVÉ HÉTÉROCYCLIQUE CONTENANT DU SOUFRE AYANT UNE ACTIVITÉ INHIBANT LA β-SÉCRÉTASE
JPWO2010047372A1 (ja) 2008-10-22 2012-03-22 塩野義製薬株式会社 Bace1阻害活性を有する2−アミノピリミジン−4−オンおよび2−アミノピリジン誘導体
WO2010113848A1 (fr) 2009-03-31 2010-10-07 塩野義製薬株式会社 Dérivé isothiourée ou dérivé isourée ayant une activité inhibitrice de bace1
UA110467C2 (uk) 2009-12-11 2016-01-12 Шионогі Енд Ко., Лтд. Похідні оксазину
EP2634188A4 (fr) 2010-10-29 2014-05-07 Shionogi & Co Dérivé d'aminodihydropyrimidine fusionnée
CN103261199A (zh) 2010-10-29 2013-08-21 盐野义制药株式会社 萘啶衍生物
WO2012147763A1 (fr) 2011-04-26 2012-11-01 塩野義製薬株式会社 Dérivé d'oxazine et inhibiteur de bace 1 le contenant
EP2912035A4 (fr) 2012-10-24 2016-06-15 Shionogi & Co Dérivés de dihydrooxazine ou d'oxazépine ayant une activité inhibitrice de bace1

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA73A (en) * 1869-09-27 J. Woodley Improvements in boots and shoe heels
JPH09504278A (ja) * 1944-06-01 1997-04-28 ザ、ウェルカム、ファンデーション、リミテッド Noシンターゼインヒビターとしての置換尿素およびイソチオ尿素誘導体
US3547619A (en) * 1967-01-23 1970-12-15 Gulf Research Development Co Nitrophenylacetic acids and derivatives as selective herbicides
US4007173A (en) * 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
US4065572A (en) * 1976-02-13 1977-12-27 Merck & Co., Inc. Amino acids and esters thereof useful as antihypertensive agents
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
NL7700945A (nl) * 1976-02-13 1977-08-16 Merck & Co Inc Werkwijze voor het bereiden van bloeddruk- verhogende preparaten.
CS191794B1 (en) * 1977-11-24 1979-07-31 Karel Sindelar Process for preparing/2-arylthio-4-fluorphenyl/acetic acids
JPS5939416B2 (ja) * 1981-10-16 1984-09-22 エシル コ−ポレ−シヨン ニトロアリ−ル酢酸エステル及びその誘導体の製法
JPS58194814A (ja) * 1982-05-11 1983-11-12 Nippon Shinyaku Co Ltd 免疫調節作用を有する薬剤
SE8203887D0 (sv) * 1982-06-23 1982-06-23 Kabivitrum Ab Nya trombininhiberande foreningar
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
GB8709248D0 (en) * 1987-04-16 1987-05-20 Wyeth John & Brother Ltd Azo compounds
JPH0614797A (ja) * 1992-06-30 1994-01-25 Nagase & Co Ltd 光学活性2−アリールプロピオン酸及びそのエステルの製造方法
DK0690851T3 (da) 1993-03-23 1999-11-08 Astra Ab Guanidin-derivater, som er anvendelige til behandling
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
EP0763016B1 (fr) * 1994-06-01 2000-01-26 Axys Pharmaceuticals, Inc. Compositions et procedes de traitement d'etats induits par des mastocytes
GB9418912D0 (en) 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds

Also Published As

Publication number Publication date
AU4124096A (en) 1996-07-03
GEP20012439B (en) 2001-05-25
RU2167858C2 (ru) 2001-05-27
EP0798292A1 (fr) 1997-10-01
EP0798292A4 (fr) 2000-04-12
JPH08269006A (ja) 1996-10-15
JP3655685B2 (ja) 2005-06-02
NZ296594A (en) 2000-02-28
HUP0600438A2 (en) 2006-08-28
WO1996018607A1 (fr) 1996-06-20
NO972666L (no) 1997-08-12
ES2232828T3 (es) 2005-06-01
KR100339299B1 (ko) 2003-05-09
HK1039316A1 (zh) 2002-04-19
HK1008867A1 (en) 1999-07-16
EP0798292B1 (fr) 2004-11-03
FI972460A7 (fi) 1997-08-11
BR9510006A (pt) 1997-11-11
LT97119A (lt) 1998-02-25
US6534546B1 (en) 2003-03-18
NZ501319A (en) 2000-07-28
TW474909B (en) 2002-02-01
CZ179697A3 (cs) 1998-03-18
CN1310169A (zh) 2001-08-29
FI972460A0 (fi) 1997-06-10
CZ290655B6 (cs) 2002-09-11
WO1996018608A1 (fr) 1996-06-20
AU2136099A (en) 1999-06-17
CN1075808C (zh) 2001-12-05
AU2629795A (en) 1996-07-03
CA2206005C (fr) 2006-05-02
NO972666D0 (no) 1997-06-10
NO310615B1 (no) 2001-07-30
DE69533727D1 (en) 2004-12-09
AU713544B2 (en) 1999-12-02
DE69533727T2 (de) 2005-10-27
LT4343B (lt) 1998-05-25
CA2206005A1 (fr) 1996-06-20
CN1172473A (zh) 1998-02-04
ATE281430T1 (de) 2004-11-15
AU705152B2 (en) 1999-05-13

Similar Documents

Publication Publication Date Title
FI972460A7 (fi) Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus
FI960628L (fi) Amidiinijohdannaisia, joilla on typpioksidisyntetaasiaktiivisuuksia
EE9900281A (et) Lämmastikoksiidi süntaasi inhibiitorid
NO991951D0 (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
FI951731L (fi) Heterosykliset yhdisteet, joilla on sokeritautia vastustava vaikutus, niiden valmistus ja käyttö
FI971970A7 (fi) Aniliinijohdoksia
TR199501209A2 (tr) Urea türevleri
HUT77977A (hu) Javított multi-drog-rezisztencia aktivitással rendelkező aminosavszármazékok
DK1084104T3 (da) Nitrogenoxidsynthaseinhibitorer
FI953523L (fi) Fenyyli-3-dimetyyliamino-propaaniyhdisteet, joilla on farmakologista vaikutusta
IS5635A (is) Indólýl-3-glýoxýlsýru afleiður með virkni gegn æxlum
PT900210E (pt) Derivados azahexano heterociclicos com actividade antviral
FI951298L (fi) 2-amino-4-fenyyli-4-oksovoihappojohdannaiset, joilla on kynureninaasia ja/tai kynureniini-3-hydroksylaasia inhiboiva aktiivisuus
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
ID23780A (id) Nitrik oksida penghambat infeksi phinovirus
NO964022D0 (no) -2-antichymotrypsinanaloger med elastasehemmende aktivitet
NO306299B1 (no) Oksatiolaner og farmasöytiske preparater med antiviral virkning som inneholder de samme
IS4791A (is) 2-Amínó-5,6-díklóróbenzimídazól afleiður með virkni gegn veirum
FI963222A7 (fi) 6-substituoitu 4-amino-mykofenolihappo ja sen johdannaiset, joilla on immunosuppressiivista aktiivisuutta
FI951996A7 (fi) 4-kinolinyylijohdannaiset, joilla on Helicobakteerin vastaista aktiivisuutta
DK0731078T3 (da) Terpenquinon med antitumoraktivitet
FI960026L (fi) Värejä, joissa on tetra-aminopyrimidiiniä ja suoravärjäysaineita
ES1035944Y (es) Envase semirigido perfeccionado.
AU705152C (en) Aniline derivatives possessing an inhibitory effect of nitric oxide synthase
BR7700293U (pt) Disposição em pára-raios